Genomatica Stock

genomatica.comSpecialty MaterialsFounded: 2000Funding to Date: $283.52MM

Genomatica is the developer of manufacturing processes that enable their licensee partners to produce the world’s most widely-used chemicals a ‘better way,’ from alternative feedstocks, with better economics and greater sustainability than petroleum-based processes.

Register for Details

For more details on financing and valuation for Genomatica, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Christophe Schilling Ph.D
Co-Founder, Chief Executive Officer & Board Member
Priti Pharkya
Director of Strategy and Corporate Development
Jeff Lievense Ph.D
Senior Advisor to the CEO, Bioengineering & Technology & Executive Vice President, Engineering
Kaspar Evertz
Executive Vice President, Commercial
Steve Weiss
Head of Marketing

Board Members

Boris Ryabov Ph.D
Bright Capital
Carlos Cabrera
Christophe Schilling Ph.D
Leighton Read MD
Alloy Ventures
Michael Savage
Robert Pangborn Ph.D
Steve Jurvetson
Draper Fisher Jurvetson Management
Thomas Huot Ph.D
VantagePoint Capital Partners
William Baum
William Caesar

Other companies like Genomatica in the Specialty Materials sector

Sector
Last Round Est. Valuation
$4.06B
Sector
Last Round Est. Valuation
$1.82B
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$140MM
Sector
Last Round Est. Valuation
$1.7B

News

Adds capabilities to meet increasing demand for sustainable products
Accelerates expansion of product lines; strengthens partnership with Ginkgo Bioworks